Patient characteristics | HCC | non-HCC malignancies | non-HCC benign lesions |
---|---|---|---|
No. of patients | 165 | 30 | 16 |
No. of lesions | 173 | 32 | 24 |
Sex (male) | 133 (80.6%) | 24 (80.0%) | 12 (75.0%) |
Age (years, mean [range]) | 51.2 (26–83) | 53.6 (39–77) | 49.1 (30–60) |
Size (cm, mean ± SD) | 5.74 ± 3.17 | 5.64 ± 2.36 | 2.93 ± 2.43 |
Interval between MR imaging and surgery (d, mean ± SD) | 2.73 ± 1.99 | 2.81 ± 2.25 | 4.62 ± 7.13 |
Underlying Diseases | |||
 HBV-related cirrhosis | 108 | 10 | 6 |
 HBV carrier (not cirrhotic) | 52 | 16 | 9 |
 Cirrhosis of other causes | 5 | 4 | 1 |
Child-Pugh Class | |||
 A | 164 (99.4%) | 27 (90.0%) | 16 (100.0%) |
 B | 1 (0.6%) | 3 (10.0%) | 0 |
ALT (IU/L) | |||
 >40 | 68 (41.2%) | 6 (20.0%) | 2 (12.5%) |
AST (IU/L) | |||
 >35 | 84 (50.9%) | 7 (23.3%) | 1 (6.3%) |
TBIL (umol/L) | |||
 >28.0 | 11 (6.7%) | 4 (13.3%) | 1 (6.3%) |
IBIL (umol/L) | |||
 >20.0 | 6 (3.6%) | 5 (16.7%) | 1 (6.3%) |
ALB (g/L) | |||
 <35 | 4 (2.4%) | 2 (6.7%) | 0 |
PT (s) | |||
 >12.8 | 42 (25.5%) | 4 (13.3%) | 0 |
PLT (×10^9/L) | |||
 <100 | 30 (18.2%) | 3 (10.0%) | 2 (12.5%) |
HBsAg (COI) | |||
 >10 | 105 (84.8%) | 12 (40.0%) | 9 (56.3%) |
AFP (ng/ml) | |||
 >20 | 105 (63.6%) | 10 (33.3%) | 1 (6.3%) |
CEA (ng/ml) | |||
 >3.4 | 29 (17.6%) | 11 (36.7%) | 1 (6.3%) |
CA 19–9 (U/ml) | |||
 >22 | 68 (41.2%) | 15 (50.0%) | 0 |